Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents
Caroline Machado Kopruszinski(Universidade Federal do Paraná), Frank Porreca(University of Arizona), Yeon Sun Lee, W. Schmidt(Canadian Blood Services), Laurie A. VanderVeen(Gilead Sciences (United States)), Juliana Swiokla(University of Arizona), Edita Navratilova(University of Arizona), Miao Yang(Nektar Therapeutics (United States)), Takahiro Miyazaki(Nektar Therapeutics (United States)), Yi Liu(Nektar Therapeutics (United States)), Jonathan Zalevsky(Nektar Therapeutics (United States))
Cited by 10
Related Papers
Central modulation of pain
|Journal of Clinical Investigation|2010|1.1k
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
|The Journal of Cell Biology|2000|816
Enhanced antibody half-life improves in vivo activity
|Nature Biotechnology|2010|654
JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
|Journal of Biological Chemistry|2005|403